BACKGROUND Dilated cardiomyopathy(DCM)is a common cause of systolic heart failure,and is the most prevalent type of non-ischemic cardiomyopathy.Primary hyperparathyroidism(PHPT)is characterized by hypercalcemia and ex...BACKGROUND Dilated cardiomyopathy(DCM)is a common cause of systolic heart failure,and is the most prevalent type of non-ischemic cardiomyopathy.Primary hyperparathyroidism(PHPT)is characterized by hypercalcemia and excessive secretion of parathyroid hormone(PTH).Generally,PHPT is asymptomatic and is incidentally identified during routine laboratory assessments.CASE SUMMARY This case report details a 52-year-old man diagnosed with DCM and refractory hypercalcemia,who presented with clinical manifestations including dyspnea,recurrent anorexia,and abdominal distention.Laboratory investigations indicated an elevated serum PTH level,and the sestamibi scan suggested the presence of a parathyroid adenoma.Hence,the patient underwent a parathyroidectomy,which pathologically confirmed the diagnosis of a parathyroid adenoma.Postoperatively,the patient's hypercalcemia was corrected,the dimensions of the cardiac chambers were reduced,and there was a marked improvement in cardiac function.CONCLUSION Our findings emphasize the importance of PTH assessment in patients with DCM and concurrent hypercalcemia.展开更多
目的分析住院Graves病患者骨代谢状况及^(131)I治疗后骨代谢指标的转归。方法收集315例Graves病住院患者的临床资料,分析骨代谢特点,并与300例健康人群进行病例对照研究。随访^(131)I治疗后1年的Graves病患者60例,分析治疗前后骨代谢指...目的分析住院Graves病患者骨代谢状况及^(131)I治疗后骨代谢指标的转归。方法收集315例Graves病住院患者的临床资料,分析骨代谢特点,并与300例健康人群进行病例对照研究。随访^(131)I治疗后1年的Graves病患者60例,分析治疗前后骨代谢指标的变化。结果与健康对照人群相比,Graves病患者骨转化指标(OCN、P1NP、β-cTX、尿钙/肌酐)增高,骨密度(bone mineral density,BMD)降低,甲状腺激素水平与骨转化指标呈正性相关,与全髋BMD(Z值)呈负性相关,与腰椎、股骨颈BMD(Z值)则未见线性相关。^(131)I治疗后1年的Graves病患者骨转化指标较治疗前明显下降,BMD部分上升。结论 Graves病患者骨转化增快,BMD下降,^(131)I治疗后随着病情好转,高骨转化速率得到遏制,BMD部分恢复。展开更多
基金Supported by Sichuan Province Science and Technology Program,No.2024YFHZ0214 and No.2023YFS0299Chengdu Science and Technology Program,No.2024-YF05-01820-SN.
文摘BACKGROUND Dilated cardiomyopathy(DCM)is a common cause of systolic heart failure,and is the most prevalent type of non-ischemic cardiomyopathy.Primary hyperparathyroidism(PHPT)is characterized by hypercalcemia and excessive secretion of parathyroid hormone(PTH).Generally,PHPT is asymptomatic and is incidentally identified during routine laboratory assessments.CASE SUMMARY This case report details a 52-year-old man diagnosed with DCM and refractory hypercalcemia,who presented with clinical manifestations including dyspnea,recurrent anorexia,and abdominal distention.Laboratory investigations indicated an elevated serum PTH level,and the sestamibi scan suggested the presence of a parathyroid adenoma.Hence,the patient underwent a parathyroidectomy,which pathologically confirmed the diagnosis of a parathyroid adenoma.Postoperatively,the patient's hypercalcemia was corrected,the dimensions of the cardiac chambers were reduced,and there was a marked improvement in cardiac function.CONCLUSION Our findings emphasize the importance of PTH assessment in patients with DCM and concurrent hypercalcemia.
文摘目的分析住院Graves病患者骨代谢状况及^(131)I治疗后骨代谢指标的转归。方法收集315例Graves病住院患者的临床资料,分析骨代谢特点,并与300例健康人群进行病例对照研究。随访^(131)I治疗后1年的Graves病患者60例,分析治疗前后骨代谢指标的变化。结果与健康对照人群相比,Graves病患者骨转化指标(OCN、P1NP、β-cTX、尿钙/肌酐)增高,骨密度(bone mineral density,BMD)降低,甲状腺激素水平与骨转化指标呈正性相关,与全髋BMD(Z值)呈负性相关,与腰椎、股骨颈BMD(Z值)则未见线性相关。^(131)I治疗后1年的Graves病患者骨转化指标较治疗前明显下降,BMD部分上升。结论 Graves病患者骨转化增快,BMD下降,^(131)I治疗后随着病情好转,高骨转化速率得到遏制,BMD部分恢复。
